Study on the Safety of Abatacept in Relapsing Polychondritis

Phase 1 Completed 4 enrolled Benaroya Research Institute Bristol-Myers Squibb · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test the safety of the study drug abatacept and see what effects (good and bad) it has in patients with relapsing polychondritis.

Timeline

Start: 2011-01
Primary completion: 2012-05
Completion: 2012-05

Publications

Peng SL, Rodriguez D. Abatacept in relapsing polychondritis. Ann Rheum Dis. 2013 Aug;72(8):1427-9. doi: 10.1136/annrheumdis-2013-203319. Epub 2013 Apr 20. No abstract available.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Abatacept	Other / unclassified	125 mg	Subcutaneous

Study on the Safety of Abatacept in Relapsing Polychondritis

Summary

Timeline

Publications

Drugs

Indications